ROIVANT SCIENCES LTD. (ROIV)

SEC filing

ROIVANT SCIENCES LTD.

ROIV · CIK 1635088

4 · Sep 1, 2026 · President & Immunovant CEO Venker Eric sold 200K Common Shares at $35.77/unit ($7.2M); exercised options for 400K shares

President & Immunovant CEO Venker Eric sold 200K Common Shares at $35.77/unit ($7.2M); exercised options for 400K shares

FORM 4

xslF345X06/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).